المؤلفون: Amandine Le Bourgeois, Marion Eveillard, Camille Debord, Joëlle Gaschet, Marie-C. Béné, Cyrille Touzeau, Soraya Wuilleme, Michel Chérel, Thierry Guillaume, Thomas Gastinne, Patrice Chevallier, Philippe Moreau, Catherine Godon, Benoit Tessoulin, Beatrice Mahe, Olivier Theisen, Nicolas Blin, Alice Garnier, Viviane Dubruille, Anne Lok, Pierre Peterlin, Yannick Le Bris, Steven Le Gouill

المساهمون: Nuclear Oncology (CRCINA-ÉQUIPE 13), Centre de Recherche en Cancérologie et Immunologie Nantes-Angers (CRCINA), Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Nantes - UFR de Médecine et des Techniques Médicales (UFR MEDECINE), Université de Nantes (UN)-Université de Nantes (UN)-Centre hospitalier universitaire de Nantes (CHU Nantes)-Centre National de la Recherche Scientifique (CNRS)-Université d'Angers (UA)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Nantes - UFR de Médecine et des Techniques Médicales (UFR MEDECINE), Université de Nantes (UN)-Université de Nantes (UN)-Centre hospitalier universitaire de Nantes (CHU Nantes)-Centre National de la Recherche Scientifique (CNRS)-Université d'Angers (UA), Immunobiology of Human αβ and γδ T Cells and Immunotherapeutic Applications (CRCINA-ÉQUIPE 1), Centre hospitalier universitaire de Nantes (CHU Nantes), Regulation of Bcl2 and p53 Networks in Multiple Myeloma and Mantle Cell Lymphoma (CRCINA-ÉQUIPE 10), CRLCC René Gauducheau, Integrative Oncogenomics of Multiple Myeloma Pathogenesis and Progression (CRCINA-ÉQUIPE 11), Université d'Angers (UA)-Université de Nantes (UN)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS)-Centre hospitalier universitaire de Nantes (CHU Nantes)-Université d'Angers (UA)-Université de Nantes (UN)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS)-Centre hospitalier universitaire de Nantes (CHU Nantes), Bernardo, Elizabeth

المصدر: Cancer Medicine, Vol 10, Iss 2, Pp 642-648 (2021)
Cancer Medicine
Cancer Medicine, Wiley, 2021, 10 (2), pp.642-648. ⟨10.1002/cam4.3648⟩
Cancer Medicine, 2021, 10 (2), pp.642-648. ⟨10.1002/cam4.3648⟩

مصطلحات موضوعية: 0301 basic medicine, Oncology, Male, Cancer Research, Response to therapy, medicine.medical_treatment, 0302 clinical medicine, Antineoplastic Combined Chemotherapy Protocols, prognostic biomarker, Original Research, Potential impact, biology, Myeloid leukemia, Induction Chemotherapy, Middle Aged, Prognosis, lcsh:Neoplasms. Tumors. Oncology. Including cancer and carcinogens, Pathophysiology, 3. Good health, Survival Rate, Leukemia, Myeloid, Acute, Cytokine, 030220 oncology & carcinogenesis, Female, Adult, medicine.medical_specialty, Induction Phase, [SDV.CAN]Life Sciences [q-bio]/Cancer, acute myeloid leukemia, lcsh:RC254-282, 03 medical and health sciences, [SDV.CAN] Life Sciences [q-bio]/Cancer, Internal medicine, medicine, Biomarkers, Tumor, Humans, FLT3 ligand, Radiology, Nuclear Medicine and imaging, Interleukin 6, Aged, IL-6, business.industry, Interleukin-6, Clinical Cancer Research, Membrane Proteins, IL‐6, 030104 developmental biology, biology.protein, business, Intermediate risk, Follow-Up Studies

وصف الملف: application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::262f7e0de03e9e6d90c9e1482ebf7947Test
https://doaj.org/article/489f420bf9c943fa9f0afed8b3326dcaTest

المؤلفون: Marie-Therese Rubio, Roberta Di Blasi, Gilles Salles, Miguel A Perales, Kada Klouche, Muriel Picard, Pierre Sesques, Eric Mariotte, Michael Darmon, Boris Böll, Philippe R. Bauer, Sanjay Chawla, Kevin Rakszawski, Nahema Issa, Anne Huynh, Guillaume Cartron, Florence Rabian, Peter Borchmann, Michael Joannidis, Sabine Furst, Sophie de Guibert, Lara Zafrani, Patrice Ceballos, Nicolas Boissel, David Beauvais, Catherine Thieblemont, François-Xavier Gros, Alberto Mussetti, Gabriel Moreno-González, Adel Maamar, Florent Wallet, Faezeh Legrand, Julien Leroy, Quentin Quelven, Djamel Mokart, Valentin Ortiz, Christian Recher, Jakob Rudzki, Laura Platon, Pleun Hemelaar, Benoit Tessoulin, Reuben Benjamin, Sandrine Valade, Pedro Castro, Gennadii Galstian, Amélie Seguin, Peter Schellongowski, Anna Sureda, Alice Gallo De Moraes, Philipp Wohlfarth, Bruno Levy, Andry Van de Louw, Jorge Garcia Borrega, Julio Delgado, Ibrahim Yakoub-Agha, Nathalie Fégueux, Laveena Munshi, Yi Lin, Emmanuel Bachy, Stéphanie Harel, Sara Fernández, Bertrand Arnulf, Thomas Gastinne, Elie Azoulay, Didier Blaise, Amandine Le Bourgeois, Louis Voigt, Cécile Borel, Anne-Sophie Moreau, Christian Chabannon, Ulrich Jäger, Virginie Lemiale, Olga Gavrilina, Victoria Metaxa, Thomas Staudingert, Edouard Forcade

المساهمون: Hopital Saint-Louis [AP-HP] (AP-HP), Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP), University of Barcelona, CHU Pontchaillou [Rennes], Centre d'Investigation Clinique [Rennes] (CIC), Université de Rennes (UR)-Hôpital Pontchaillou-Institut National de la Santé et de la Recherche Médicale (INSERM), King's College Hospital (KCH), Mayo Clinic [Rochester], Memorial Sloane Kettering Cancer Center [New York], Weill Medical College of Cornell University [New York], Centre Hospitalier Lyon Sud [CHU - HCL] (CHLS), Hospices Civils de Lyon (HCL), Physiologie & médecine expérimentale du Cœur et des Muscles [U 1046] (PhyMedExp), Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Montpellier (UM)-Centre National de la Recherche Scientifique (CNRS), Centre Hospitalier Régional Universitaire [Montpellier] (CHRU Montpellier), Institut Universitaire du Cancer de Toulouse - Oncopole (IUCT Oncopole - UMR 1037), Université Toulouse III - Paul Sabatier (UT3), Université de Toulouse (UT)-Université de Toulouse (UT)-Centre Hospitalier Universitaire de Toulouse (CHU Toulouse)-Institut National de la Santé et de la Recherche Médicale (INSERM), Hôpital Roger Salengro [Lille], Penn State Health Milton S. Hershey Medical Center, Pennsylvania Commonwealth System of Higher Education (PCSHE)-Penn State System, Centre hospitalier universitaire de Nantes (CHU Nantes), Institut Paoli-Calmettes, Fédération nationale des Centres de lutte contre le Cancer (FNCLCC), Universitätsklinikum Köln (Uniklinik Köln), Hôpital Saint-André, Défaillance Cardiovasculaire Aiguë et Chronique (DCAC), Centre Hospitalier Régional Universitaire de Nancy (CHRU Nancy)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Lorraine (UL), Centre Hospitalier Régional Universitaire de Nancy (CHRU Nancy), Radboud University Medical Center [Nijmegen], Universitat de Barcelona (UB), University of Toronto, Medizinische Universität Wien = Medical University of Vienna, Leopold Franzens Universität Innsbruck - University of Innsbruck, Centre de Recherche en Cancérologie de Marseille (CRCM), Aix Marseille Université (AMU)-Institut Paoli-Calmettes, Fédération nationale des Centres de lutte contre le Cancer (FNCLCC)-Fédération nationale des Centres de lutte contre le Cancer (FNCLCC)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS), Institut de Génétique Moléculaire de Montpellier (IGMM), Université de Montpellier (UM)-Centre National de la Recherche Scientifique (CNRS), Groupe de Recherche Respiratoire en Réanimation Onco-Hématologique, Université de Rennes 1 (UR1), Université de Rennes (UNIV-RENNES)-Université de Rennes (UNIV-RENNES)-Hôpital Pontchaillou-Institut National de la Santé et de la Recherche Médicale (INSERM), Université de Montpellier (UM)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS), CHU Toulouse [Toulouse]-Université Toulouse III - Paul Sabatier (UT3), Université Fédérale Toulouse Midi-Pyrénées-Université Fédérale Toulouse Midi-Pyrénées-Institut National de la Santé et de la Recherche Médicale (INSERM), Service de Soins Intensifs [CHRU Nancy], Radboud University Medical Centre [Nijmegen, The Netherlands], University of Innsbruck, National Research Center for Hematology [Moscow, Russia]

المصدر: The Lancet Haematology
The Lancet Haematology, 2021, 8 (5), pp.e355-e364. ⟨10.1016/S2352-3026(21)00060-0⟩
The Lancet Haematology, Elsevier, 2021, 8 (5), pp.e355-e364. ⟨10.1016/S2352-3026(21)00060-0⟩
Lancet Haematology, 8, E355-E364
Dipòsit Digital de la UB
Universidad de Barcelona
Lancet Haematology, 8, 5, pp. E355-E364

مصطلحات موضوعية: Male, MESH: Neurotoxicity Syndromes, MESH: Registries, [SDV]Life Sciences [q-bio], MESH: Multiple Myeloma, Immunotherapy, Adoptive, Severity of Illness Index, law.invention, MESH: Proportional Hazards Models, Medicina intensiva, Clinical trials, 0302 clinical medicine, law, Clinical endpoint, Medicine, Infection control, Registries, MESH: Treatment Outcome, MESH: Middle Aged, Medical record, Hazard ratio, [SDV.MHEP.HEM]Life Sciences [q-bio]/Human health and pathology/Hematology, Hematology, MESH: Follow-Up Studies, Middle Aged, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Intensive care unit, 3. Good health, Survival Rate, Cytokine release syndrome, Intensive Care Units, Treatment Outcome, 030220 oncology & carcinogenesis, MESH: Immunotherapy, Adoptive, Female, Neurotoxicity Syndromes, Lymphoma, Large B-Cell, Diffuse, Cytokine Release Syndrome, Multiple Myeloma, Care of the sick, Cohort study, Adult, medicine.medical_specialty, Critical Care, MESH: Survival Rate, Other Research Radboud Institute for Molecular Life Sciences [Radboudumc 0], MESH: Cytokine Realease Syndrome, 03 medical and health sciences, All institutes and research themes of the Radboud University Medical Center, MESH: Critical Care, Internal medicine, Intensive care, MESH: Severity of Illness Index, Humans, Cura dels malalts, Critical care medicine, Proportional Hazards Models, MESH: Precursor Cell Lymphoblastic Leukemia-Lymphoma, MESH: Humans, business.industry, MESH: Lymphomz, Large B-Cell, Diffuse, MESH: Adult, MESH: Intensive care Units, medicine.disease, MESH: Male, business, MESH: Female, Assaigs clínics, 030215 immunology, Follow-Up Studies

وصف الملف: application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::10e0221bac10970ab09383fbb48e5504Test
https://hdl.handle.net/2066/241124Test

المؤلفون: Maud D'Aveni-Piney, Catherine Thieblemont, Caroline Bodet-Milin, Loic Ysebaert, Pierre Feugier, Eugenio Galli, Marie-Thérèse Rubio, Roberta Di Blasi, Pierre Bories, Benoit Tessoulin, Pierre Olivier, Ingrid Lafon, Alina Berriolo-Riedinger, Sylvie Chevret, Sophie Bernard, Laetitia Vercellino, Céline Bossard, Salim Kanoun, Lucie Oberic, Pascal Merlet, Michel Meignan, Olivier Casasnovas, Steven Le Gouill, Véronique Meignin, Cédric Rossi

المساهمون: Hopital Saint-Louis [AP-HP] (AP-HP), Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP), Service de Médecine Nucléaire [Toulouse], CHU Toulouse [Toulouse], Centre de Recherche en Cancérologie et Immunologie Nantes-Angers (CRCINA), Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Nantes - UFR de Médecine et des Techniques Médicales (UFR MEDECINE), Université de Nantes (UN)-Université de Nantes (UN)-Centre hospitalier universitaire de Nantes (CHU Nantes)-Centre National de la Recherche Scientifique (CNRS)-Université d'Angers (UA), Lipides - Nutrition - Cancer [Dijon - U1231] (LNC), Université de Bourgogne (UB)-AgroSup Dijon - Institut National Supérieur des Sciences Agronomiques, de l'Alimentation et de l'Environnement-Institut National de la Santé et de la Recherche Médicale (INSERM), Service d'Hématologie [CHRU Nancy], Centre Hospitalier Régional Universitaire de Nancy (CHRU Nancy), Ingénierie Moléculaire et Physiopathologie Articulaire (IMoPA), Université de Lorraine (UL)-Centre National de la Recherche Scientifique (CNRS), Service d'Hématologie [IUCT Toulouse], Université Fédérale Toulouse Midi-Pyrénées-Institut Universitaire du Cancer de Toulouse - Oncopole (IUCT Oncopole - UMR 1037), Université Toulouse III - Paul Sabatier (UT3), Université Fédérale Toulouse Midi-Pyrénées-Université Fédérale Toulouse Midi-Pyrénées-CHU Toulouse [Toulouse]-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université Toulouse III - Paul Sabatier (UT3), Université Fédérale Toulouse Midi-Pyrénées-CHU Toulouse [Toulouse]-Institut National de la Santé et de la Recherche Médicale (INSERM), Service de Médecine Nucléaire [Nantes], Hôpital Laennec, Service de Médecine Nucléaire [Nancy], Service de Médecine Nucléaire, Centre Georges-François Leclerc [Dijon] (CGFL), Centre Régional de Lutte contre le cancer Georges-François Leclerc [Dijon] (UNICANCER/CRLCC-CGFL), UNICANCER-UNICANCER, Centre hospitalier universitaire de Nantes (CHU Nantes), Nutrition-Génétique et Exposition aux Risques Environnementaux (NGERE), Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Lorraine (UL), CHU Henri Mondor, Service de biostatistiques et information médicale [Saint-Louis], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Groupe Hospitalier Saint Louis - Lariboisière - Fernand Widal [Paris], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Université de Paris (UP), NF-kappaB, Différenciation et Cancer (OncokappaB (URP_7324)), Université de Paris (UP)

المصدر: Blood Advances
Blood Advances, The American Society of Hematology, 2020, 4 (22), pp.5607-5615. ⟨10.1182/bloodadvances.2020003001⟩

مصطلحات موضوعية: 0301 basic medicine, medicine.medical_specialty, [SDV.CAN]Life Sciences [q-bio]/Cancer, Immunotherapy, Adoptive, Gastroenterology, 03 medical and health sciences, 0302 clinical medicine, International Prognostic Index, Refractory, Internal medicine, medicine, Humans, Progression-free survival, Stage (cooking), Retrospective Studies, Univariate analysis, business.industry, [SDV.MHEP.HEM]Life Sciences [q-bio]/Human health and pathology/Hematology, Hematology, medicine.disease, Progression-Free Survival, Confidence interval, Tumor Burden, 3. Good health, Lymphoma, 030104 developmental biology, 030220 oncology & carcinogenesis, Lymphoma, Large B-Cell, Diffuse, business, Diffuse large B-cell lymphoma

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3b79f675b2891c55ed31da5653be9089Test
https://doi.org/10.1182/bloodadvances.2020003001Test

المؤلفون: Steven Le Gouill, Ana Berceanu, A. Dormoy, Patrice Chevallier, Yohan Desbrosses, Caroline Malugani, Céline Bressollette, Berthe-Marie Imbert, Benoit Tessoulin, Thomas Gastinne, Eric Deconinck, Beatrice Mahe, Nicolas Blin, Philippe Moreau, Thierry Guillaume, Marie C. Béné, Marion Eveillard, Sophie Vantyghem, Amandine Le Bourgeois, Alix Duquesne, Etienne Daguindau, Yannick Le Bris, Alice Garnier, Cyrille Touzeau, Viviane Dubruille, Anne Lok, Pierre Peterlin

المصدر: Acta Oncologica. 60:466-474

مصطلحات موضوعية: Adult, Male, medicine.medical_specialty, Transplantation Conditioning, Post transplant cyclophosphamide, Graft vs Host Disease, Peripheral Blood Stem Cells, Gastroenterology, 030218 nuclear medicine & medical imaging, Young Adult, 03 medical and health sciences, 0302 clinical medicine, Immune system, immune system diseases, Internal medicine, Acute graft versus host disease, medicine, Humans, Clofarabine, Radiology, Nuclear Medicine and imaging, In patient, Cyclophosphamide, Aged, Retrospective Studies, business.industry, Hematopoietic Stem Cell Transplantation, Hematology, General Medicine, Middle Aged, Prognosis, Peripheral blood, surgical procedures, operative, Oncology, 030220 oncology & carcinogenesis, Female, Good prognosis, business, medicine.drug

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::44473c26b006301b7d5e4d414f07c1c1Test
https://doi.org/10.1080/0284186x.2020.1837947Test

المؤلفون: Clementine Joubert, Steven Le Gouill, Clémentine Sarkozy, Corinne Haioun, Kamal Bouabdallah, Emmanuel Gyan, Catherine Thieblemont, Remy Gressin, Guillaume Cartron, Barbara Burroni, Olivier Casasnovas, Olivier Hermine, Benoit Tessoulin, Thierry Lamy

المصدر: Annals of Hematology. 99:1771-1778

مصطلحات موضوعية: Oncology, medicine.medical_specialty, Cyclophosphamide, business.industry, Hematology, General Medicine, medicine.disease, Temsirolimus, 3. Good health, Fludarabine, Clinical trial, 03 medical and health sciences, 0302 clinical medicine, hemic and lymphatic diseases, 030220 oncology & carcinogenesis, Internal medicine, medicine, Refractory Mantle Cell Lymphoma, Cytarabine, Mantle cell lymphoma, Rituximab, business, 030215 immunology, medicine.drug

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_________::acc91eebf6ab6b39c9e88f114c1f5b4dTest
https://doi.org/10.1007/s00277-020-04159-3Test

المؤلفون: Beatrice Mahe, Nicolas Blin, Alix Duquesne, Alice Garnier, Anne Lok, Pierre Peterlin, Marie C. Béné, Marion Eveillard, Amandine Le Bourgeois, Thomas Gastinne, Thierry Guillaume, Viviane Dubruille, Cyrille Touzeau, Philippe Moreau, Steven Le Gouill, Patrice Chevallier, Benoit Tessoulin

المصدر: Annals of Hematology. 99:1341-1350

مصطلحات موضوعية: Adult, Male, medicine.medical_specialty, Transplantation Conditioning, CD3 Complex, Cyclophosphamide, Antigens, CD34, Context (language use), Gastroenterology, Cohort Studies, Young Adult, 03 medical and health sciences, 0302 clinical medicine, Internal medicine, medicine, Humans, Clofarabine, Aged, Retrospective Studies, Hematology, business.industry, Incidence (epidemiology), Graft Survival, Hematopoietic Stem Cell Transplantation, General Medicine, Middle Aged, Fludarabine, Transplantation, Treatment Outcome, 030220 oncology & carcinogenesis, Cohort, Female, business, Immunosuppressive Agents, Follow-Up Studies, 030215 immunology, medicine.drug

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f9f819735a2fa9fe5e3fac72ce75957cTest
https://doi.org/10.1007/s00277-020-04031-4Test

المؤلفون: Claire Dromer, Antoine Néel, Hélène Maillard, Denis Jullien, Anne-Maelle Fontenoy, Carla Araujo, Gwenaël Lorillon, Fleur Cohen-Aubart, Mohamed Hamidou, Loïc Guillevin, Mathilde de Menthon, Benoit Tessoulin, Abdellatif Tazi, Mathieu Artifoni, Jean Donadieu, Julien Haroche, Jean-Emmanuel Kahn, Olivier Hermine, Thierry Généreau

المصدر: British Journal of Haematology. 189:869-878

مصطلحات موضوعية: Adult, Male, medicine.medical_specialty, Neutropenia, Antimetabolites, medicine.medical_treatment, Kaplan-Meier Estimate, Gastroenterology, 03 medical and health sciences, 0302 clinical medicine, Langerhans cell histiocytosis, Sepsis, Internal medicine, medicine, Humans, Age of Onset, Cladribine, Proportional Hazards Models, Retrospective Studies, Aged, 80 and over, Chemotherapy, Dose-Response Relationship, Drug, Cumulative dose, business.industry, Remission Induction, Hematology, Middle Aged, medicine.disease, Vinblastine, Histiocytosis, Langerhans-Cell, Histiocytosis, Virus Diseases, 030220 oncology & carcinogenesis, Cytarabine, Female, France, business, Immunosuppressive Agents, 030215 immunology, medicine.drug

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9c1537d8c8eea94e1c0426535df1e0c0Test
https://doi.org/10.1111/bjh.16449Test

المؤلفون: Anne Lok, Pierre Peterlin, Viviane Dubruille, Steven Le Gouill, Sophie Vanthygem, Marianne Coste-Burel, Patrice Chevallier, Benoit Tessoulin, Berthe-Marie Imbert, Marie C. Béné, Nicolas Blin, Philippe Moreau, Thomas Drumel, Alice Garnier, Thierry Guillaume, Amandine Le Bourgeois, Beatrice Mahe, Maxime Jullien, Thomas Gastinne, Cyrille Touzeau

المساهمون: Centre hospitalier universitaire de Nantes (CHU Nantes), Centre de Recherche en Cancérologie et Immunologie Nantes-Angers (CRCINA), Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Nantes - UFR de Médecine et des Techniques Médicales (UFR MEDECINE), Université de Nantes (UN)-Université de Nantes (UN)-Centre hospitalier universitaire de Nantes (CHU Nantes)-Centre National de la Recherche Scientifique (CNRS)-Université d'Angers (UA), Immunobiology of Human αβ and γδ T Cells and Immunotherapeutic Applications (CRCINA-ÉQUIPE 1), Université de Nantes (UN)-Université de Nantes (UN)-Centre hospitalier universitaire de Nantes (CHU Nantes)-Centre National de la Recherche Scientifique (CNRS)-Université d'Angers (UA)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Nantes - UFR de Médecine et des Techniques Médicales (UFR MEDECINE), Bernardo, Elizabeth, Université d'Angers (UA)-Université de Nantes (UN)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS)-Centre hospitalier universitaire de Nantes (CHU Nantes), Université d'Angers (UA)-Université de Nantes (UN)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS)-Centre hospitalier universitaire de Nantes (CHU Nantes)-Université d'Angers (UA)-Université de Nantes (UN)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS)-Centre hospitalier universitaire de Nantes (CHU Nantes)

المصدر: British Journal of Haematology
British Journal of Haematology, Wiley, 2021, Online ahead of print. ⟨10.1111/bjh.17818⟩
British Journal of Haematology, 2021, Online ahead of print. ⟨10.1111/bjh.17818⟩

مصطلحات موضوعية: Male, Antibodies, Viral, Immunotherapy, Adoptive, Immunogenicity, Vaccine, 0302 clinical medicine, vaccine, Antineoplastic Combined Chemotherapy Protocols, Medicine, CAR‐T cells, 030212 general & internal medicine, Antigens, Viral, ComputingMilieux_MISCELLANEOUS, Receptors, Chimeric Antigen, Lymphoma, Non-Hodgkin, Vaccination, Hematopoietic Stem Cell Transplantation, Hematology, Middle Aged, Precursor Cell Lymphoblastic Leukemia-Lymphoma, SARS-CoV-2 mRNA, Combined Modality Therapy, 3. Good health, 030220 oncology & carcinogenesis, Spike Glycoprotein, Coronavirus, Female, Car t cells, COVID 19, Adult, 2019-20 coronavirus outbreak, Fever, Coronavirus disease 2019 (COVID-19), CAR-T cells, Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), Immunization, Secondary, Receptors, Antigen, T-Cell, Pain, [SDV.CAN]Life Sciences [q-bio]/Cancer, SARS‐CoV‐2 mRNA, Immunocompromised Host, Young Adult, 03 medical and health sciences, [SDV.CAN] Life Sciences [q-bio]/Cancer, Correspondence, Humans, In patient, BNT162 Vaccine, Aged, Biological Products, Messenger RNA, SARS-CoV-2, business.industry, COVID-19, Virology, Antibody response, Immunoglobulin G, BNT162b2, business

وصف الملف: application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::72a5757e662faa464759e471038abc45Test
https://www.hal.inserm.fr/inserm-03388040/documentTest

المؤلفون: Romain, Lécuyer, Nahema, Issa, Benoit, Tessoulin, Rose-Anne, Lavergne, Florent, Morio, Frederic, Gabriel, Emmanuel, Canet, Céline, Bressollette-Bodin, Aurélie, Guillouzouic, David, Boutoille, François, Raffi, Raphael, Lecomte, Paul, Le Turnier, Colin, Deschanvres, Fabrice, Camou, Benjamin Jean, Gaborit

المصدر: The Journal of infectious diseases. 225(5)

مصطلحات موضوعية: Male, medicine.medical_specialty, Population, Congenital cytomegalovirus infection, Cytomegalovirus, HIV Infections, Pneumocystis carinii, Serology, Internal medicine, Epidemiology, medicine, Immunology and Allergy, Humans, Respiratory system, education, Retrospective Studies, education.field_of_study, business.industry, Coinfection, Pneumonia, Pneumocystis, Pneumocystis jirovecii Pneumonia, Retrospective cohort study, Middle Aged, medicine.disease, Infectious Diseases, Cytomegalovirus Infections, SOFA score, Female, business

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::18042c70b02c79ca153847b38d36781cTest
https://pubmed.ncbi.nlm.nih.gov/34604908Test

المؤلفون: Julien Lazarovici, Michel Meignan, Driss Chaoui, Hervé Ghesquières, C. Borel, Alain Delmer, Christophe Bonnet, T. Lamy, Benoit Tessoulin, A. Traverse Glehen, Anne-Claire Gac, Pierre Feugier, Kamal Bouabdallah, Aspasia Stamatoullas, F. Bras, Pauline Brice, Olivier Casasnovas, J. M. Shiano del colella, Luc‐M. Fornecker, Thomas Gastinne, H. Moatti

المصدر: Hematological Oncology. 39

مصطلحات موضوعية: Oncology, Cancer Research, medicine.medical_specialty, Consolidation (soil), business.industry, Phases of clinical research, Hematology, General Medicine, Classical Hodgkin's Lymphoma, Stage i ii, ABVD, Internal medicine, medicine, In patient, Brentuximab vedotin, business, medicine.drug

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_________::62019703bce446f02756bf2fde34f939Test
https://doi.org/10.1002/hon.111_2880Test